Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 9/20 | 0.37 |
| ▸ | GSK3B | P49841 | 7/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.33 |
| ▸ | FYN | P06241 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14547314 | 0.83 | GSK3B (0.52) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL14547315 | 0.75 | GSK3B (0.48) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL13998533 | 0.72 | GSK3B (0.51) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL13993126 | 0.72 | CDK2 (0.67) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL13998487 | 0.69 | GSK3B (0.52) | CDK2GSK3BCCNE1 | |
| SCHEMBL13309220 | 0.69 | GSK3B (0.47) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL13885051 | 0.69 | GSK3B (0.65) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL14547251 | 0.69 | CDK2 (0.33) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL14547249 | 0.69 | CDK2 (0.33) | CDK2GSK3BCHEK1CCNA2CCNA1 | |
| SCHEMBL12952885 | 0.67 | GSK3B (0.76) | CDK2GSK3BCCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007044401-A2 | NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |